AC Immune SA (ACIU)
$2.67-$0.06 (-2.21%) Today
Latest ACIU Insider Trades
Andrea Pfeifer - OfficerOpen-market sale$28K
Andrea Pfeifer - OfficerAC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 10 | 336,703 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
7 Form 4 filings on record, the earliest from Apr 16, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Roy Ervin Twyman - Director | Grant or award | Common Share | 16,568 | $0.00 | - | |
| Roy Ervin Twyman - Director | Grant or award | Share Option (right to buy) | 38,889 | $0.00 | - | |
| Renee Aguiar-Lucander - Director | Grant or award | Common Share | 16,568 | $0.00 | - | |
| Renee Aguiar-Lucander - Director | Grant or award | Share Option (right to buy) | 38,889 | $0.00 | - | |
| Martin Zuegel - Officer | Grant or award | Share Option (right to buy) | 77,778 | $0.00 | - | |
| Martin Zuegel - Officer | Grant or award | Common Share | 33,136 | $0.00 | - | |
| Monika Buetler - Director | Grant or award | Common Share | 17,751 | $0.00 | - | |
| Monika Buetler - Director | Grant or award | Share Option (right to buy) | 41,667 | $0.00 | - | |
| Carl Howard June - Director | Grant or award | Share Option (right to buy) | 38,889 | $0.00 | - | |
| Carl Howard June - Director | Grant or award | Common Share | 16,568 | $0.00 | - | |
| Andrea Pfeifer - Officer | Open-market sale | Common Share | 10,000 | $2.79 | $28K | |
| Andrea Pfeifer - Officer | Open-market purchase | Share | 10,000 | $3.14 | $31K |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR |
AC Immune SA (ACIU) had 5 insider filings in the last 90 days, with the most recent on 2026-06-15. The full record for ACIU runs to 7 Form 4 filings, the earliest from 2026-04-16. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ACIU were filed in the last 90 days. 1 purchase is on record for this company.
No insider sales of ACIU were filed in the last 90 days. 1 sale is on record for this company.
This page tracks ACIU Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ACIU to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
$ACLOXAristotle Pacific Enhanced CLO Income Fund
$ACPabrdn Income Credit Strategies Fund
$ACRGAmerican Clean Resources Group, Inc.
$ACURACURA PHARMACEUTICALS, INC
$ACVVirtus Diversified Income & Convertible Fund
$ACXPAcurx Pharmaceuticals, Inc.
$ADACAmerican Drive Acquisition Co
$ADAGAdagene Inc.
$ADBTAdvasa Holdings, Inc.
$ADCTADC Therapeutics SAEvery Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.